The National Institute of Mental Health is overhauling its funding strategy to emphasize the translation of advances in genomics and information technology into therapies.

A biotech breakthrough sparks a high-stakes patent war, and two new films follow people with autism looking for love.

The gene-editing tool CRISPR gets scaled down for mice, and omega-3 fatty acids come up short for autism.

The creators of CRISPR call for a ban on editing the human genome, and critics weigh in on a widely used autism therapy.

A new study is the first rigorous test of a controversial idea: that the everyday interactions between caregiver and child can shape the course of autism.

Researchers home in on the cerebellum’s role, and an app helps children with autism make eye contact.

A cluster of neurons helps monkeys cooperate, and a human gene makes a mouse brain look like a person’s.

Drugs designed to treat fragile X syndrome have yet to show substantial benefits in people. But rather than abandon them, child neurologist Elizabeth Berry-Kravis suggests a new way to measure their effectiveness.

Imagine a world in which researchers reveal all their clinical trial data, allowing their peers to do their own analyses and confirm the findings. A new report by the Institute of Medicine outlines ways to make this scenario a reality.

By analyzing stem cells derived from baby teeth, researchers have tracked a child’s autism to mutations in a gene called TRPC6. The molecular saga highlights a painless way to probe the role some genes play in autism.